Purpose
To manufacture Omicron variant SARS-CoV-2 virus to support the development of low-cost effective mucosal vaccines.
Grantee
Division
Global Health
Date
OCTOBER 2023
Region served
GLOBAL
Committed amount
$2,818,036
Grant topic
Vaccine Development
Duration (months)
62
Grantee location
Saint-Herblain, France
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.